comparemela.com

Page 2 - Psychemedics Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Massachusetts drug testing firm targeting fentanyl relocates corporate HQ to Dallas

Massachusetts drug testing firm targeting fentanyl relocates corporate HQ to Dallas
dallasnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallasnews.com Daily Mail and Mail on Sunday newspapers.

United statesBrian hullingerPsychemedics corpTerms of serviceValley roadIts actonCulver cityDallas morning new

Psychemedics: Q3 Earnings Snapshot -November 09, 2023 at 05:55 pm EST

ACTON, Mass. ACTON, Mass. Psychemedics Corp. on Thursday reported a loss of $2 million in its third quarter. The Acton, Massachusetts-based company said it had a loss of 36 cents per.

United statesZacks investment researchPsychemedics corpAutomated insights

The Drug Screening Market size to grow by USD 6 6599 billion from 2022 to 2027; Advancements in Drug Screening Technologies to Influence Market Growth

/PRNewswire/ The drug screening market is expected to grow by USD 6,659.87 million during the five-year forecast period, according to Technavio. As per the.

United kingdomUnited statesJesse maidaDrug screening servicesAmerica holdingsCompany market positioningF hoffmann la roche ltdQuest diagnostics incOrasure technologies incBombardier recreational products incShimadzu corpLifeloc technologies incOmega laboratories incCompany landscapeTechnavio researchMarket positioning of companies

Psychemedics Co Declares Quarterly Dividend of $0 07 (NASDAQ:PMD)

Psychemedics Co. (NASDAQ:PMD – Get Rating) declared a quarterly dividend on Tuesday, May 9th, Zacks reports. Stockholders of record on Thursday, May 25th will be given a dividend of 0.07 per share on Thursday, June 8th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 5.21%. The ex-dividend date of […]

Werner baumgartnerPsychemedics corpExchange commissionCannell capitalPsychemedics coGet ratingTrading downAnnette baumgartnerPsychemedics dailyNasdaq pmd

Psychemedics Co (NASDAQ:PMD) Sees Large Decline in Short Interest

Psychemedics Co. (NASDAQ:PMD – Get Rating) saw a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 12,200 shares, a decline of 19.2% from the March 15th total of 15,100 shares. Based on an average daily trading volume, of 5,300 shares, the days-to-cover ratio is […]

Werner baumgartnerPsychemedics coSecurities exchange commissionWedbush securities incPsychemedics corpGet ratingAnnette baumgartnerPsychemedics dailyNasdaq pmd

vimarsana © 2020. All Rights Reserved.